𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effect of simvastatin, an inhibitor of hydroxy-methylglutaryl coenzyme a reductase, on the growth of human ito cells

✍ Scribed by Ariane Mallat; Anne-Marie Preaux; Sylvie Blazejewski; Daniel Dhumeaux; Jean Rosenbaum; Philippe Mavier


Publisher
John Wiley and Sons
Year
1994
Tongue
English
Weight
685 KB
Volume
20
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

✦ Synopsis


During hepatic fibrogenesis, Ito cells proliferate, acquire a myofibroblastlike phenotype and synthesize increased amounts of extracellular matrix components. In this study, we have assessed the effects of simvastatin, an inhibitor of hydroxy-methylglutaryl-coenzyme A reductase, on the growth of human myofibroblastlike Ito cells. Cells were grown from explants of normal human liver and characterized by a positive staining for desmin and smooth muscle alpha-actin. Simvastatin (0.1 to 10 mumol/L) induced a marked dose-dependent decrease of [3H]thymidine incorporation in human Ito cells, whether stimulated by human serum or by purified growth factors. Simvastatin-induced inhibition of DNA synthesis was confirmed by nuclear autoradiography and was not explained by a cytotoxic effect. The growth inhibitory effect of simvastatin was specifically due to inhibition of hydroxy-methylglutaryl-coenzyme A reductase because it was overcome by addition of mevalonic acid, the product of the enzymatic reaction. The reduction in [3H]thymidine incorporation was not affected by supplementation of culture medium with purified cholesterol-low-density lipoprotein or isopentenyl adenine. It was partially reversed by addition of farnesol. These results show that simvastatin decreases the growth of human Ito cells, independently of its effect on cholesterol synthesis. This decrease may be due in part either to reduced farnesylation of proteins involved in growth factor signaling pathway or to inhibition of N-linked protein glycosylation. Whether this effect exists in vivo and could thus lead to a parallel decrease of fibrosis deposition within the liver requires further study.


πŸ“œ SIMILAR VOLUMES


Relative lipophilicities, solubilities,
✍ Abu T. M. Serajuddin; Sunanda A. Ranadive; Eileen M. Mahoney πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 532 KB

The apparent octanol-water partition coefficients (Po/w) and aqueous solubilities for four 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors [pravastatin, lovastatin (mevinolin), mevastatin (compactin), and simvastatin (synvinolin)] were compared. Pravastatin is highly hydrophilic

The effects of the 3-hydroxy, 3-methylgl
✍ Jan W. A. Smit; Karel J. Van Erpecum; Willem Renooij; Mark F. J. Stolk; Patrick πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 800 KB

3-hydroxy,3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors reduce biliary cholesterol saturation index (CSI) in duodenal bile in hypercholesterolemic patients and might be useful for gallstone dissolution. However, preliminary data suggest that these drugs are not effective in this respect

A facile synthesis of lanost-8-en-3Ξ²-ol-
✍ Edward J. Parish; Hiroshi Honda; Sarawanee Chitrakorn; Frederick R. Taylor πŸ“‚ Article πŸ“… 1988 πŸ› Elsevier Science 🌐 English βš– 361 KB

A facile chemical synthesis of lanost-8-en-3 beta-ol-24-one (24-ketolanosterol) is described. This compound was found to be a potent inhibitor of 3-hydroxy-3-methylglutaryl (HMG) CoA reductase activity in cultured mouse L cells. The synthetic scheme developed in this study utilizes commercial lanost

Elevation of HeLa cell 3-hydroxy-3-methy
✍ Dr. Webster K. Cavenee; George Melnykovych πŸ“‚ Article πŸ“… 1979 πŸ› John Wiley and Sons 🌐 English βš– 968 KB

Elevation of 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMG-CoA reductase, EC 1.1.1.34) activity by glucocorticoids was shown to be dependent on the concentration of hormone in the medium over a range of 5 X

Simvastatin, 3-hydroxy-3-methylglutaryl
✍ Kwang Seok Ahn; Gautam Sethi; Madan M. Chaturvedi; Bharat B. Aggarwal πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 French βš– 631 KB

## Abstract Simvastatin, an inhibitor of 3‐hydroxy‐3‐methylglutaryl coenzyme A reductase, is a cholesterol‐lowering drug that may play a role in bone metabolism through a mechanism that is not fully understood. Recently, receptor activator of NF‐κB ligand (RANKL), a member of the TNF superfamily, h